More than 50% of melanoma cases harbor a mutation in the viral v-raf murine sarcoma serine/threonine-kinase oncogene homolog B1 (B-RAF) proto-oncogene, mimicking an activating phosphorylation by RAS. Here, BRAF is linked to melanoma.